Post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) at the Kitengela sub-county hospital, on February 27, 2024. [File, Standard]
Mary Auma chose love with open eyes. At just 19, she married a man living with HIV—armed not with denial, but with determination and daily doses of Pre-Exposure Prophylaxis (PrEP), the pill she believed would shield her from infection. But now, a year later, that shield is cracking.
Since their marriage in early 2024, she has relied on PrEP– a medication taken by HIV-negative individuals before sex to reduce the risk of transmission from an HIV-positive partner.
Facts First
This story continues on The Standard INSiDER. Subscribe now for unfiltered journalism that holds power to account.
Already have an account? Login
The Standard Group Plc is a multi-media organization with investments in media
platforms spanning newspaper print
operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a
leading multi-media house in Kenya with a key influence in matters of national
and international interest.